Across the world, women live longer than men. The reason behind the difference between male and female life expectancy is unclear, but it seems related partially to biological advantages and partially to environmental and behavioral factors. Even though women outlive men, they are more prone to suffering from ill health and other age-related diseases. Women's healthcare, however, especially in less-developed settings, remains mostly confined to reproductive issues, particularly maternal health. Attention to other significant women’s health issues such as oncology, reproductive health, and urology is growing rapidly.
Overall, the advancements in women’s health diagnostic products are intense, and diagnostic technologies have been subjected to rapid change. Two of the key market drivers are the rising occurrence of lifestyle disorders among women and growing awareness of women-specific health issues. The other drivers include the rise in the number of private diagnostic labs mostly in the emerging nations, health initiatives/drives taken by governments and other health organizations, and new approvals for easy-to-use rapid tests. Nevertheless, the lack of skillful lab professionals and high set-up costs of diagnostic devices/systems are some key restraints to growth in the women’s health diagnostics market.
Currently, women’s health diagnostic products are being targeted at markets outside of the traditional hospital or clinical laboratory. In fact, the demand for home healthcare services in women’s health is facing a steady increase, but, at the same time, there is pressure to lower costs and maintain the high quality of the care delivered at home. Continuous improvements in technology are bringing about a number of new diagnostic tests that consolidate high levels of accuracy with rapid, easy-to-use product designs.
Cardiovascular disease (CVD), which includes stroke and coronary heart disease (CHD), is the leading cause of death and disability in women. The onset of CHD in women is delayed by about 10 years due to the presence of estrogen prior to menopause. The rising global burden of CVD and increasing patient awareness of health monitoring are currently driving growth in the cardiovascular diagnostic market. The increasing popularity of patient-friendly diagnostics has opened up several opportunities for advanced cardiovascular devices. Overall, the market is shifting towards miniaturized, portable, easy-to-use, and cost-effective diagnostic devices.
This strategic research service provides the key growth drivers and current competitive landscape in the women's cardiology diagnostics market. Also, it covers the market size and growth rate forecast for 2016 and 2021.
The women's cardiology diagnostics market has been categorized into point-of-care (POC)/molecular tests, drug infusion pumps, patient monitoring, wearables, and surgical instrumentation.
Key Questions This Study Will Answer:
What are the key opportunities that make this an attractive market with significant future revenue potential for companies?
What is the growth potential for women’s cardiology diagnostics solutions and sub-segments across different geographies?
What are the key growth drivers that companies should focus on to remain relevant and competitive in this market?
Who are the top game-changing companies in the women’s cardiology diagnostics market and what are their leading product portfolios?